Effects of intravenous GSK3858279 on a battery of evoked pain tests in healthy volunteers

Trial Identifier: 209973
Sponsor: GlaxoSmithKline
Collaborator:
Not Applicable
Start Date: October 2019
Primary Completion Date: September 2021
Study Completion Date: September 2021
Condition: Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Netherlands LEIDEN, Netherlands, 2333 CL